With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Few treatments have revolutionised care for people with chronic inflammatory disorders more than biologic and small molecule ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The XEC variant of Covid is quickly becoming the dominant strain of the winter, but the current vaccines may not be as ...

This week, Johnson & Johnson JNJ began the third-quarter earnings season for the drug and biotech sector. The FDA granted ...

The drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.

Even previous versions of the vaccine built from XEC’s predecessors like omicron might not be as effective against the new ...

With utilities, pipelines, and REITs fully priced and at times dividend-light, yield-hungry investors should consider ...

A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or ...